As p53 represses the PRR11-SKA2 transcription unit in lung cancer, it is conceivable that patients with lower expression of either PRR11 or SKA2 along with wild type p53 reflect the bona fide functional wild type p53 and hence show the best outcome. Here, SKA2 is linked to lung cancer.